Advertisement
Taking Action

Advocacy

  • The Cost of Treatment

    As efforts to change or repeal the Affordable Care Act continue, health care bills keep piling up for many cancer patients and caregivers.

    by Sue Rochman

  • Advocacy in Action

    Fearless Friends

    Lori Marx-Rubiner and AnneMarie Ciccarella met on social media and grew close through their cancer research advocacy.

    by Sue Rochman

  • Scholarships for Survivors

    Cancer survivor creates scholarship fund for young adult cancer survivors.

    by Lindsey Konkel

  • Breaking Down a Cancer Diagnosis

    During her husband's treatment for metastatic prostate cancer, Jan Manarite learned what questions to ask. Now she shares what she learned with others.

    by Marci A. Landsmann

  • Forward Look

    Scientists Take a Stand

    Thousands of attendees who gathered at the Opening Ceremony of the American Association for Cancer Research (AACR) Annual Meeting 2017 sent a message on April 2 that cuts proposed by the Trump administration to the National Institutes of Health (NIH) budget would be devastating to cancer research, stall progress and ultimately harm cancer patients. The Annual […]

    by Sue Rochman

  • A New Look for Clinical Trials

    More focused efforts aim to increase the number and type of participants in research studies. One goal is for study participants to be more like the patients who will take the drug if it is approved.

    by Sue Rochman

  • Survivor Profile

    The Gift of Music

    A self-taught musician takes what he has learned from his experience with kidney cancer to entertain, teach and inspire.

    by Jenny Song

  • Q&A

    Trial Guide

    Researcher Tom Marsilje is helping fellow colorectal cancer patients sort through clinical trials.

    by Kate Yandell

  • AACR Scientist↔Survivor Program: The Patient Perspective

    In a sea of p-values and distribution curves, patient advocates and survivors at a scientific gathering remind researchers who is behind the numbers.

    by Marci A. Landsmann

  • Patient Advocates Go to Washington

    Patient advocates meet amid an outcry about research funding cuts, participate in a meeting with FDA officials and visit Capitol Hill.

    by Marci A. Landsmann